Evaluating the association of APOA2 polymorphism with insulin resistance in adolescents
- PMID: 25606421
- PMCID: PMC4287816
- DOI: 10.1016/j.mgene.2014.04.007
Evaluating the association of APOA2 polymorphism with insulin resistance in adolescents
Abstract
Background: 265T>C SNP in the APOA-II gene promoter may be associated with obesity risk and insulin resistance (IR). This study aims to analyze the association between the APOA2 - 265T>C SNP and risk for obesity and IR in adolescents.
Material and methods: The study was conducted on 500 adolescents. They were 240 obese and 260 non-obese individuals, aged 16-21 years old. Their mean age was 18.25 ± 2.54 years. Variables examined body weight, height, waist circumference (WC), systolic and diastolic blood pressure (BP), body fat percentage (BF%), and abdominal visceral fat layer. Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) was used as a biomarker for IR. BF% was assessed by body composition analyzer and abdominal visceral fat thickness was determined by ultrasonography. The APOA2 - 265T>C polymorphism genotype was analyzed by PCR amplification of a 273-bp fragment.
Results: Genotype frequencies were in Hardy-Weinberg equilibrium. The frequency of the mutant C allele was significantly higher in obese cases than non-obese cases. After multivariate adjustment, waist, BF%, visceral adipose layer and HOMA-IR were significantly higher in homozygous allele CC carriers than TT + TC carriers. Homozygous individuals for the CC allele had statistically higher values of energy intake, total fat (g/day) and saturated fat (SATFAT) than carriers of the T allele.
Conclusions: Homozygous individuals for the C allele had higher obesity risk than carriers of the T allele and had elevated levels of visceral adipose tissue. Moreover, the present study shows that the CC polymorphism is associated with the development of IR [OR 1.89 (1.35-2.91), P = .012] and remains significant after adjusting for gender, age and body mass index.
Keywords: APOA2 polymorphism; Adolescents; Anthropometry; Insulin resistance; Obesity; Visceral fat.
References
-
- Albu J.B., Murphy L., Frager D.H., Johnson J.A., Pi-Sunyer F.X. Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes. 1997;46:456–462. - PubMed
-
- Armellini F., Zamboni M., Rigo L., Bergamo A.I.A., Robbi R., Marchi M. Sonography detection of small intra-abdominal fat variations. Int. J. Obes. 1991;15:847–852. - PubMed
-
- Björntorp P. Obes. Lancet. 1997;350:423–426. - PubMed
-
- Blanco-Vaca F., Escola-Gil J.C., Martin-Campos J.M., Julve J. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J. Lipid Res. 2001;42:1727–1739. - PubMed
-
- Castellani L.W., Goto A.M., Lusis A.J. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes. 2001;50:643–651. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
